Figure 2From: Metabolic effect of telmisartan and losartan in hypertensive patients with metabolic syndromeEffect of telmisartan and losartan during the OGTT in patients with metabolic syndrome. A) Plasma glucose at baseline. B) Plasma glucose at endpoint. C) Plasma insulin at baseline. D) Plasma insulin at endpoint.Back to article page